Science backed, doctor led plan
American Association for the Advancement of Science
American Association for the Advancement of Science
American Association for the Advancement of Science
Innovators who fought to unlock GLP-1 drugs for obesity were awarded breakthrough of the year award.
PubMed Central
American Association for the Advancement of Science
American Association for the Advancement of Science
By taking semaglutide, participants achieved an average of 14.9% body weight loss.
.png/:/rs=w:365,h:365,cg:true,m/cr=w:365,h:365)
Semaglutide and Cardiovascular Outcomes
American Association for the Advancement of Science
Semaglutide and Cardiovascular Outcomes
People with heart disease and excess weight (but no diabetes), who took weekly semaglutide had fewer heart attacks, strokes, or heart-related deaths.